melanoma (skin)

Showing NaN - NaN of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)

Completed
  • Intraocular Melanoma
  • +2 more
  • Santa Monica, California
  • +11 more
Jun 15, 2021

Melanoma (Skin) Trial run by the CC (aldesleukin, filgrastim, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +6 more
  • Bethesda, Maryland
  • +1 more
Jun 30, 2017

Kidney Cancer, Melanoma (Skin), Metastatic Cancer Trial run by the CC (questionnaire administration, 3-dimensional conformal

Terminated
  • Kidney Cancer
  • +5 more
  • questionnaire administration
  • +4 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Nov 16, 2016

Melanoma (Skin) Trial run by the CC (biological, drug, radiation)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +5 more
  • Bethesda, Maryland
  • +1 more
Oct 6, 2015

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015

Kidney Cancer, Melanoma (Skin) Trial run by the NCI (recombinant CD40-ligand, recombinant flt3 ligand)

Completed
  • Kidney Cancer
  • Melanoma (Skin)
  • recombinant CD40-ligand
  • recombinant flt3 ligand
  • Bethesda, Maryland
    Surgery Branch
Apr 29, 2015

Melanoma (Skin) Trial in Bethesda, Houston (adenovirus RSV-TK, ganciclovir)

Completed
  • Melanoma (Skin)
  • Bethesda, Maryland
  • +2 more
Apr 28, 2015

Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, gp100 antigen)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Surgery Branch
Apr 28, 2015

Kidney Cancer, Melanoma (Skin) Trial run by the NCI (denileukin diftitox)

Completed
  • Kidney Cancer
  • Melanoma (Skin)
  • denileukin diftitox
  • Bethesda, Maryland
  • +1 more
Jun 18, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Colorectal Cancer, Endometrial Cancer, Head Neck Cancer Trial run by the NCI (aldesleukin, ras peptide cancer vaccine,

Completed
  • Colorectal Cancer
  • +8 more
  • aldesleukin
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Bethesda, Maryland
    Surgery Branch
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, vaccinia-tyrosinase vaccine)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, sargramostim)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +4 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, gp209-2M antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, gp100 antigen)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • aldesleukin
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (NY-ESO-1 peptide vaccine, aldesleukin, filgrastim)

Completed
  • Melanoma (Skin)
  • NY-ESO-1 peptide vaccine
  • +6 more
  • Bethesda, Maryland
  • +1 more
Jun 18, 2013

Melanoma (Skin), Non-melanomatous Skin Cancer Trial run by the NIAMS (isotretinoin)

Completed
  • Melanoma (Skin)
  • Non-melanomatous Skin Cancer
  • Bethesda, Maryland
    Intramural Research Program
Jun 17, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, recombinant tyrosinase-related protein-2)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (NY-ESO-1 peptide vaccine, aldesleukin)

Completed
  • Melanoma (Skin)
  • NY-ESO-1 peptide vaccine
  • aldesleukin
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, recombinant fowlpox-tyrosinase vaccine, vaccinia-tyrosinase vaccine)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013